FindTrial
Sign In

A study to explore patient survival in patients with non-small cell lung cancer complicated with oligometastasis

A multi-centre real-world non-interventional observational study to explore patient survival in patients with non-smal cell lung cancer complicated with oligometastasis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014703
Enrollment
Unknown
Registered
2018-01-30
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Patients with surgeries group:Surgeries
Patients with non-surgery treatments group:Non-surgery treatments

Sponsors

Tangdu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients who were enrolled in clinics from 2014 to 2017 and met all the following criteria will be included in the study: 1. Patients aged >= 18 years old; 2. Pathologically or cytohistologically diagnosed non-small cell lung cancer; 3. Patients with no more than 3 extrapulmonary lymph metastases in one organ.

Exclusion criteria

Exclusion criteria: 1. Intrapulmonary metastases or primary lung cancer; 2. Patients with pleural dissemination or extrapulmonary direct invasion; 3. Patients with supraclavicular lymph node metastasis; 4. Patients with systematic diseases without any follow-up visits.

Design outcomes

Primary

MeasureTime frame
Overall survival in the subgroups of patients with surgeries and non-surgery treatments;—

Secondary

MeasureTime frame
Disease-free survival in the subgroups of patients with surgeries and non-surgery treatments;—

Countries

China

Contacts

Public ContactXiaofei Li

Tangdu Hospital

lxfchest@fmmu.edu.cn+86 15009266699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026